Distribution and characterization of hemolytic activity by an oral anaerobe from the Streptococcus milleri group.
D000328:Adult; D000818:Animals; D001427:Bacterial Toxins / Q000032:analysis* / Q000037:antagonists & inhibitors; D002648:Child; D002784:Cholesterol / Q000494:pharmacology; D002918:Chymotrypsin / Q000494:pharmacology; D003545:Cysteine / Q000494:pharmacology; D004229:Dithiothreitol / Q000494:pharmacology; D019286:Endopeptidase K / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D006460:Hemolysin Proteins / Q000032:analysis* / Q000187:drug effects; D006801:Humans; D008623:Mercaptoethanol / Q000494:pharmacology; D009055:Mouth / Q000382:microbiology*; D011402:Pronase / Q000494:pharmacology; D011480:Protease Inhibitors / Q000494:pharmacology; D011817:Rabbits; D034364:Streptococcus milleri Group / Q000378:metabolism*; D020860:Subtilisin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D001427:Bacterial Toxins; D006460:Hemolysin Proteins; D011480:Protease Inhibitors; D008623:Mercaptoethanol; D002784:Cholesterol; D002918:Chymotrypsin; D014357:Trypsin; D020860:Subtilisin; D019286:Endopeptidase K; D011402:Pronase; D005978:Glutathione; D003545:Cysteine; D004229:Dithiothreitol